Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study highlights extent of antibiotic use in horses
"The surveillance of equine antimicrobial usage helps the veterinary profession demonstrate their commitment to the responsible prescribing of antibiotics in the horse" - Dr Sarah Allen, VetCompass.
Twenty per cent of equines received systemic antimicrobial drugs in 2018.

As World Antimicrobial Awareness Week gets underway (18-24 November), new research by the Royal Veterinary College (RVC) has revealed the extent of the use of systemic antimicrobials in UK equine practice.

The first-of-its-kind study, published in the Equine Veterinary Journal, also uncovers the lack of routine culture and sensitivity testing, particularly before the prescription of 'last resort' Category B antimicrobials.

Until now, little research has been carried out to monitor equine antimicrobial use in the UK. In this study, researchers analysed the prescription data and clinical notes of some 64,000 horses, ponies and donkeys from 2018, supplied by 39 veterinary practices participating in the UK VetCompass programme.

Their findings show that in 2018, around 20 per cent of equines attended by the participating veterinary practices were prescribed an antimicrobial licensed for systemic administration. Of these, nine per cent received a Category B 'highest priority' antimicrobial – whose efficacy needs to be preserved for the treatment of serious illnesses in human medicine.

The study also highlights several risk factors associated with increased antimicrobial usage. Scientists found that the highest usage groups of Category B antimicrobials were equines under the age of one, racehorses and Thoroughbreds. Meanwhile, the most common disorders treated with antimicrobials were urogenital, integumentary and respiratory conditions.

It is hoped that the study will encourage others to consider and benchmark their own usage and promote more responsible antimicrobial prescriptions – especially those deemed to be of the highest critical importance.

Dr Sarah Allen, VetCompass Data Analyst, RVC said: "The surveillance of equine antimicrobial usage helps the veterinary profession demonstrate their commitment to the responsible prescribing of antibiotics in the horse.

“We hope that by reporting on how commonly antimicrobials are prescribed to horses, and demonstrating where stewardship may be improved, others will look to compare and better their own prescribing of these vital medicines.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.